An Open-Label, Randomized, Single-Dose, 2-Way Crossover Study In Healthy Subjects Assessing The Pharmacokinetics And Safety Of Powder For Oral Suspension Of Sildenafil Citrate Administered Under Fasted And Fed Conditions
Latest Information Update: 29 Jan 2021
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- 31 Aug 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 13 Aug 2012 New trial record